Third Major Vaccine Candidate Starting Phase 3 Trial In U.S.

Third Major Vaccine Candidate Starting Phase 3 Trial In U.S.

Newsy

Published

Watch VideoAnother major coronavirus vaccine trial has reached its final and biggest hurdle.

British drugmaker AstraZeneca's vaccine candidate is now the third to start a Phase 3 trial in the U.S. That means it's in its final stage of testing.

It was developed in partnership with Oxford University.

The company says the...

Full Article